Quick charity verification for Gbs Cidp Foundation International (EIN: 222474769)
Verdict: Gbs Cidp Foundation International appears trustworthy
85/100Mission Score
$6.3MRevenue
$16.7MAssets
2Red Flags
4Strengths
Red Flags
Lack of specific, itemized executive compensation details in public filings.
The organization's liabilities have shown a general upward trend over the past few years, from $278,749 in 2016 to $1,722,069 in 2023.
Strengths
Consistently strong program spending, with a high percentage of expenses dedicated to programs.
Significant growth in revenue from $1,839,276 in 2017 to $6,141,343 in 2023, indicating increasing support.
Healthy asset growth, from $7,527,264 in 2016 to $15,123,436 in 2023, demonstrating financial stability.
Clear and consistent mission focus on GBS and CIDP.
AI Transparency Report
Gbs Cidp Foundation International is a diseases, disorders & medical disciplines nonprofit based in Conshohocken, Pennsylvania, with reported revenue of $6.3M and assets of $16.7M. Our AI analysis assigns a Mission Score of 85/100 (Excellent). Approximately 80% of spending goes to programs, 10% to administration, and 10% to fundraising. Executive compensation for the CEO is not explicitly detailed in the publicly available Form 990s, making it difficult to assess its reasonableness relative to the organization's revenue and assets. Revenue has grown +314% across 13 filing periods.